These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3048535)

  • 1. Application of mammary serum antigen assay in the management of breast cancer: a preliminary report.
    Tjandra JJ; Russell IS; Collins JP; Stacker SA; McKenzie IF
    Br J Surg; 1988 Aug; 75(8):811-7. PubMed ID: 3048535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of mammary serum antigen in sera from breast cancer patients using monoclonal antibody 3E1.2.
    Stacker SA; Thompson CH; Sacks NP; Tjandra J; Lowe MG; Bishop J; McKenzie IF
    Cancer Res; 1988 Dec; 48(24 Pt 1):7060-6. PubMed ID: 3191482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mammary serum antigen (MSA) and CA15-3 levels in the serum of patients with breast cancer.
    Sacks NP; Stacker SA; Thompson CH; Collins JP; Russell IS; Sullivan JA; McKenzie IF
    Br J Cancer; 1987 Dec; 56(6):820-4. PubMed ID: 2449238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary serum antigen (MSA) in advanced breast cancer.
    Smart YC; Stewart JF; Bartlett LD; Brien JH; Forbes JF; Burton RC
    Breast Cancer Res Treat; 1990 Jul; 16(1):23-8. PubMed ID: 1698488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of MSA as a serum marker in breast cancer: a comparison with CEA.
    Stacker SA; Sacks NP; Golder J; Tjandra JJ; Thompson CH; Smithyman A; McKenzie IF
    Br J Cancer; 1988 Mar; 57(3):298-303. PubMed ID: 3355770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of mammary serum antigen (MSA) with beta 2-microglobulin (beta 2M) and carcinoembryonic antigen (CEA) assays in patients with breast cancer.
    Tjandra JJ; McLaughlin PJ; Russell IS; Collins JP; McKenzie IF
    Eur J Cancer Clin Oncol; 1988 Oct; 24(10):1633-40. PubMed ID: 3061824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary serum antigen (MSA) levels as a marker for breast cancer: a survey of blood donors and patients with cancer.
    Stacker SA; Thompson CH; Lowe MG; Sacks NP; Golder J; Carmen H; McKenzie IF
    Dev Biol Stand; 1987; 67():91-6. PubMed ID: 3609486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and biochemical characterisation of a novel breast carcinoma associated mucin-like glycoprotein defined by antibody 3E1.2.
    Stacker SA; Tjandra JJ; Xing PX; Walker ID; Thompson CH; McKenzie IF
    Br J Cancer; 1989 Apr; 59(4):544-53. PubMed ID: 2469454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors affecting MSA levels in normal women and women with breast cancer.
    Smart YC; Rogers KM; Brien JH; Stewart JF; Burton RC
    Aust N Z J Surg; 1989 Oct; 59(10):805-9. PubMed ID: 2818340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of mammary serum antigen assay with mammography in patients with breast cancer.
    Hare WS; Tjandra JJ; Russell IS; Collins JP; McKenzie IF
    Med J Aust; 1988 Oct; 149(8):402-6. PubMed ID: 3050402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of mammary serum antigen (MSA) with the histopathological findings in localised breast cancer.
    Tjandra JJ; Busmanis I; Russell IS; Collins JP; Reed RG; McKenzie IF
    Br J Cancer; 1988 Dec; 58(6):815-7. PubMed ID: 2852030
    [No Abstract]   [Full Text] [Related]  

  • 12. Use of mucin like cancer associated antigen (MCA) in the management of breast cancer.
    Laurence V; Forbes MA; Cooper EH
    Br J Cancer; 1991 Jun; 63(6):1000-4. PubMed ID: 2069833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of circulating CA15-3 and carcinoembryonic antigen levels in patients with breast cancer.
    Hayes DF; Zurawski VR; Kufe DW
    J Clin Oncol; 1986 Oct; 4(10):1542-50. PubMed ID: 2428949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MSA--a new sensitive tumor marker in breast carcinoma].
    Zahm DM; Greinke C; Nöschel H
    Zentralbl Gynakol; 1996; 118(12):659-64. PubMed ID: 9082702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of mammography and mammary serum antigen estimation for breast cancer screening.
    Ward BG; Joy GJ; Ramm LE; Baker CA; McGuckin MA
    Med J Aust; 1992 Aug; 157(3):161-4. PubMed ID: 1635488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate. A blind trial with 420 patients.
    Devine PL; McGuckin MA; Ramm LE; Ward BG; Pee D; Long S
    Cancer; 1993 Sep; 72(6):2007-15. PubMed ID: 7689923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neoadjuvant chemotherapy in stage III breast cancer.
    Alassas M; Chu Q; Burton G; Ampil F; Mizell J; Li BD
    Am Surg; 2005 Jun; 71(6):487-92. PubMed ID: 16044927
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of a tumor-associated antigen CA 15-3 in the sera of patients with breast cancer].
    Ogawa T; Izuo M; Morita H; Ishida T; Iino Y; Hoshino K; Yokoe T; Suzuki H; Murata S; Matsuzaki S
    Gan No Rinsho; 1986 Jan; 32(1):27-32. PubMed ID: 3456454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast epithelial antigen levels and breast tumor antigen content.
    Ceriani RL; Chan C
    Breast Cancer Res Treat; 1990 Nov; 17(1):55-8. PubMed ID: 2095928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a murine monoclonal antibody for detection of circulating plasma DF3 antigen levels in breast cancer patients.
    Hayes DF; Sekine H; Ohno T; Abe M; Keefe K; Kufe DW
    J Clin Invest; 1985 May; 75(5):1671-8. PubMed ID: 3889057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.